Effect of dupilumab on allergic contact dermatitis and patch testing
Open accessThe claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Jo et al found in a systematic review that patch test reactions may remain positive, change to negative, or become newly positive after dupilumab initiation.
“Although this would suggest that dupilumab has little impact on patch testing, Jo et al 27 found in a systematic review that patch test reactions may remain positive, change to negative, or become newly positive after dupilumab initiation.”
From Dupilumab for Allergic Contact Dermatitis: An Overview of Its Use and Impact on Patch Testing. (2022) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Methodological quality and synthesis of case series and case reports
Murad, M. H., Sultan, S., Haffar, S., & Bazerbachi, F. (2018) · BMJ Evidence-Based Medicine · doi:10.1136/bmjebm-2017-110853 · Cited by 2,242 · see citing works
Flagged first, then by citations
Research works printed but not linked: 9
- Elavarasi A, Prasad M, Seth T, et al. Chloroquine and hydroxy- chloroquine for the treatment of COVID-19: a systematic review and meta-analysis. J Gen Intern Med. 2020;35:3308-3314.
- Ferreira A, Oliveira-E-Silva A, Bettencourt P. Chronic treatment with hydroxychloroquine and SARS-CoV-2 infection. J Med Virol. 2021;93:755-759.
- Boulware DR, Pullen MF, Bangdiwala AS, et al. A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19. N Engl J Med. 2020;383:517-525.
- Zandman-Goddard G, Shoenfeld Y. Infections and SLE. Autoimmunity. 2005;38:473-485.
- Al-Kofahi M, Jacobson P, Boulware DR, et al. Finding the dose for hydroxychloroquine prophylaxis for COVID-19: the desperate search for effectiveness. Clin Pharmacol Ther. 2020;108:766-769. https://doi.org/10.1016/j.jaad.2020.10.098 REFERENCES · DOI
- Dhingra N, Shemer A, Da Rosa JC, et al. Molecular profiling of contact dermatitis skin identifies allergen-dependent differences in immune response. J Allergy Clin Immunol. 2014;134(2):362-372.
- Boonstra M, Rustemeyer T, Middelkamp-Hup MA. Both chil- dren and adult patients with difficult-to-treat atopic dermatitis have high prevalences of concomitant allergic contact derma- titis and are frequently polysensitized. J Eur Acad Dermatol Venereol. 2018;32(9):1554-1561.
- Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elab- oration. BMJ. 2009;62(10):e1-e34.
- Yamane MLM, Belsito DV, Glass LRD. Two differing presentations of periocular dermatitis as a side effect of dupilumab for atopic dermatitis. Orbit. 2019;38(5):390-394.
Cited by
Sorted by citations
Dupilumab for Allergic Contact Dermatitis: An Overview of Its Use and Impact on Patch Testing.
Johnson, H. (2022) · Current Psychiatry · doi:10.12788/cutis.0519 · Cited by 20 · see citing works
- Authors
- Jo, C. E., Mufti, A., Sachdeva, M., Pratt, M., & Yeung, J.
- Affiliations
- University of Ottawa (CA)
- University of Toronto (CA)
- Sunnybrook Health Science Centre (CA)
- Corresponding author
- Yeung, Jensen
- Venue
- Journal of the American Academy of Dermatology
- Publisher
- Elsevier BV
- Published
- 2021-06
- Volume
- 84
- Issue
- 6
- Pages
- 1772-1776
- ISSN
- 0190-9622 (ISSN-L)
- OpenAlex
- W3130293843
- Cited by
- 25
- References
- 1
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 4 · 2023: 10 · 2022: 4 · 2021: 2
- FWCI
- 4.44
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of the American Academy of Dermatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Dermatology › Contact Dermatitis and Allergies
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Health Sciences › Medicine › Pharmacology › Drug-Induced Adverse Reactions
- Keywords
- dupilumab, allergic contact dermatitis, patch testing, Th2 pathway, Th17 pathway, atopic dermatitis, biologic therapy
- MeSH terms
- Allergens, Dermatologic Agents, Humans, Immunity, Cellular, Patch Tests, Dermatitis, Allergic Contact, Antibodies, Monoclonal, Humanized
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
